Changes in depression in a cohort of Danish HIV-positive individuals: Time for routine screening

Sexual Health

Volumn 8, Issue 2, 2011, Pages 214-221

  Rodkjaer, Lotte ^a   Laursen, Tinne ^a   Christensen, Nils B ^a   Lomborg, Kirsten ^b   Ostergaard, Lars ^a   Sodemann, Morten ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

adherence; AIDS; compliance; psychiatry; psychological factors; stress.

Indexed keywords

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; DEPRESSION; EMOTION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT COMPLIANCE; PREVALENCE; PSYCHIATRIST; QUESTIONNAIRE; SCREENING; UNSAFE SEX;

ADOLESCENT; ADULT; COHORT STUDIES; DENMARK; DEPRESSIVE DISORDER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUESTIONNAIRES; UNSAFE SEX; YOUNG ADULT;

EID: 79957464887     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH10067     Document Type: Article

References (33)

1. Rabkin JG. HIV and depression: review and update. Curr HIV/AIDS Rep 2008; 5: 163-71. doi:10.1007/s11904-008-0025-1
2. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008; 70: 539-45. doi:10.1097/PSY. 0b013e3181777a5f
3. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 2001; 58: 721-8. doi:10.1001/archpsyc.58.8.721 (Pubitemid 32717795)
4. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 2001; 158: 725-30. doi:10.1176/appi.ajp.158.5.725 (Pubitemid 32429839)
5. Leserman J, Petitto JM, Gu H, Gaynes BN, Barroso J, Golden RN, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med 2002; 32: 1059-73. doi:10.1017/ S0033291702005949
6. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7. doi:10.1001/archinte.160.14.2101 (Pubitemid 30482715)
7. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs 2006; 66: 769-89. doi:10.2165/00003 495-200666060-00004 (Pubitemid 43765224)
8. Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther 2005; 10: 53-61. (Pubitemid 40767631)
9. Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2007; 44: 159-66. doi:10.1097/QAI.0b013e31802c2f51 (Pubitemid 46292218)
10. Lima VD, Geller J, Bangsberg DR, Patterson TL, Daniel M, Kerr T, et al. The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS 2007; 21: 1175-83. doi:10.1097/QAD.0b0 13e32811ebf57 (Pubitemid 46763288)
11. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001; 285: 1466-74. doi:10.1001/jama.285.11.1466 (Pubitemid 32221895)
12. Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry 2003; 54: 295-306. doi:10.1016/S0006-3223(03)00323-8 (Pubitemid 37267859)
13. Cruess DG, Evans DL, Repetto MJ, Gettes D, Douglas SD, Petitto JM. Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease. Biol Psychiatry 2003; 54: 307-16. doi:10.1016/S0006-3223(03)00318-4 (Pubitemid 37267860)
14. Alciati A, Gallo L, Monforte AD, Brambilla F, Mellado C. Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients. Hum Psychopharmacol 2007; 22: 33-40. doi:10.1002/hup.813 (Pubitemid 46178776)
15. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviours. Infect Dis Clin North Am 2007; 21: 181-200. doi:10.1016/j.idc.2007.01.005 (Pubitemid 46729632)
16. Rodkjaer L, Laursen T, Balle N, Sodemann M. Depression in patients with HIV is under-diagnosed: a cross-sectional study in Denmark. HIV Med 2010; 11: 46-53. doi:10.1111/j.1468-1293.2009.00741.x
17. Treisman GJ, Angelino AF. The psychiatry of AIDS. A guide to diagnosis and treatment. Baltimore, MD: The John Hopkins University Press; 2004.
18. Asch SM, Kilbourne AM, Gifford AL, Burnam MA, Turner B, Shapiro MF, et al. Under-diagnosis of depression in HIV: who are we missing? J Gen Intern Med 2003; 18: 450-60. doi:10.1046/j.1525-1497.2003.20938.x (Pubitemid 36836674)
19. Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med 2006; 7: 112-21. doi:10.1111/j.1468-1293.2006.00350.x
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
21. Lohse N, Hansen AB, Jensen-Fangel S, Kronborg G, Kvinesdal B, Pedersen C, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005; 37: 338-43. doi:10.1080/00365540510031692 (Pubitemid 40691514)
22. Hamilton M. Development of a rating scale; for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-96.
23. Dew MA, Becker JT, Sanchez J, Caldararo R, Lopez OL, Wess J, et al. Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: a longitudinal evaluation. Psychol Med 1997; 27: 395-409. (Pubitemid 27139972)
24. Atkinson JH, Grant I. Natural history of neuropsychiatric manifestations of HIV disease. Psychiatr Clin North Am 1994; 17: 17-33. (Pubitemid 24132875)
25. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006; 163: 101-8. doi:10.1176/appi.ajp.163. 1.101 (Pubitemid 43050110)
26. Blalock AC, McDaniel JS, Farber EW. Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS. Psychosomatics 2002; 43: 400-4. doi:10.1176/appi.psy.43. 5.400
27. Dray-Spira R, Gueguen A, Lert F, VESPA Study Group. Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education. Occup Environ Med 2008; 65: 112-9. doi:10.1136/oem.2007.034363 (Pubitemid 351211987)
28. Scott-Sheldon LA, Kalichman SC, Carey MP, Fielder RL. Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006. Health Psychol 2008; 27: 129-39. doi:10.1037/0278-6133.27.2.129 (Pubitemid 351626274)
29. Ironson G, O'Cleirigh C, Fletcher MA, Laurenceau JP, Balbin E, Klimas N, et al. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med 2005; 67: 1013-21. doi:10.1097/01.psy.0000188569.58998. c8 (Pubitemid 43740117)
30. Carrico AW, Antonia MH. Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials. Psychosom Med 2008; 70: 575-84. doi:10.1097/PSY.0b013e3181 7a5d30
31. Pyne JM, Asch SM, Lincourt K, Kilbourne AM, Bowman C, Atkinson H, et al. Quality indicators for depression care in HIV patients. AIDS Care 2008; 20: 1075-83. doi:10.1080/09540120701796884
32. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, et al. NeuroICoNA Study Group. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: S136-9. (Pubitemid 35453574)
33. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr 2005; 38: 432-8. doi:10.1097/01.qai.0000147524. 19122.fd (Pubitemid 40381553)